The hypertrophic and keloid scar treatment market size in 2021 stood at US$ 5.32 billion and is projected to reach US$ 15.18 billion by 2031. The market is expected to register a CAGR of 11.4% in 2023–2031. Advances in stem cell and tissue engineering are likely to remain key hypertrophic and keloid scar treatment market trends.
Factors such as an increase in road accidents and burn cases, a rise in skin disorders such as acne formation, advancements in keloid treatment approaches, and the rising popularity of aesthetic surgeries are anticipated to propel treatment use. The introduction of new technologies in the market increases the demand for treatment devices used for hypertrophic and keloid scar, due to improved efficiency and outcomes, which also play crucial roles in accelerating the growth of the market. All these factors are anticipated to benefit the hypertrophic and keloid scar treatment market during the forecast period.
A hypertrophic scar is a thickened, wide, often raised scar due to an injury. A hypertrophic scar usually is an effect of an abnormal response to a trauma or injury. Keloids are reddish nodules that are raised in appearance and develop at the site of an injury. Keloids may occur on any body part; the upper chest, shoulders, and upper back are mostly prone to keloid formation. The presence of well-established institutes for aesthetic surgery that treat scar treatments favors the market's growth. For instance, in 2006, the Department of Plastic, Reconstructive, and Aesthetic Surgery at Nippon Medical School (NMS) was established in Tokyo, Japan. Till 2020, the NMS treated ~2000 new cases of keloid and hypertrophic patients yearly. Additionally, the Chinese Herb Medicine published a research article in December 2020 for anti-hypertrophic scar ointment. It is expected to improve the blood circulation condition of hypertrophic scar tissues. Thus, it is likely to be a promising treatment for hypertrophic and keloid scar treatment.
Injuries and their deepening into the dermis are the major causes of hypertrophic and keloid scars. Injuries can be scratches, burns, cuts, sutures, surgical incisions, and more. According to the World Health Organization (WHO) data published in December 2023, road accident-led injuries are the primary cause of death among young adults aged 5–29. ~1.19 million people die yearly due to road traffic crashes. Between 20-50 million people suffer non-fatal injuries. In addition, as per the report by the National Fire Protection Association, local fire departments responded to approximately 1.5 million fires in the US in 2022. Therefore, the increasing number of accidents and burn incidents is boosting the rising demand for hypertrophic and keloid scar treatments, thereby driving market growth.
Hypertrophic scars and keloids can have significant detrimental effects on patients both psychosocially and functionally. Careful identification of patient risk factors and a comprehensive management plan are necessary to optimize outcomes. Numerous treatments, including topical and injectable corticosteroids, 5-fluorouracil, radiotherapy, lasers, and surgical excision, have been demonstrated to be effective in treating keloids. In order to lower recurrence rates, treatment should be customized based on each patient's unique risk factors with the use of combination medicines. Nonetheless, there are many different approaches to treating keloid and hypertrophic scars, and new therapeutic techniques offer options for recurrent lesions. Novel topical therapeutics, skin priming, and laser-assisted drug delivery could offer different approaches for managing keloids and hypertrophic scars, thereby fueling the market's growth during the forecast period.
Key segments that contributed to the derivation of the hypertrophic and keloid scar treatment market analysis are scar type, product type, and end user.
The geographic scope of the hypertrophic and keloid scar treatment market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the hypertrophic and keloid scar treatment market. North America market is expanding due to several factors, including the rising incidence rate of accidents, growing developments of hypertrophic and keloid scars treatment products, and an increase in skin-related disorders. For instance, in January 2020, Soliton, Inc. announced its Rapid Acoustic Pulse Device's positive results. The device is intended for the treatment of fibrotic keloid and hypertrophic scars.
In addition, the demand for over-the-counter topical products is increasing. As the products are available without a prescription, the demand for the products is growing. Various clinics and hospitals are offering treatments for keloid and hypertrophic scars, which is also responsible for augmenting the market's growth in the region. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.
The regional trends and factors influencing the Hypertrophic and Keloid Scar Treatment Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Hypertrophic and Keloid Scar Treatment Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 5.32 Billion |
| Market Size by 2031 | US$ 15.18 Billion |
| Global CAGR (2023 - 2031) | 11.4% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Scar Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Hypertrophic and Keloid Scar Treatment Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Hypertrophic and Keloid Scar Treatment Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The hypertrophic and keloid scar treatment market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for hypertrophic and keloid scar treatment and strategies:
The “Hypertrophic and Keloid Scar Treatment Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas: